Posted on 12/10/20
Gilead Sciences to Buy MYR GmbH for $1.15 Billion
Gilead Sciences, Inc. (Nasdaq: GILD) acquired MYR GmbH, a Bad Homburg, Germany-based biotechnology company focused on the development and commercialization of therapeutics
Posted on 12/10/20
Syneos Health Acquires Synteract
Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that it has completed the previously announced acquisition of Synteract,
Posted on 12/10/20
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement
ENGLEWOOD, Colo. and GRAND PRAIRIE, Texas, Dec. 10, 2020 (GLOBE NEWSWIRE) -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty pharmaceutical company focused on commercializing novel products . . .
Posted on 12/10/20
Cities That Need the Most Initial Vaccinations Against COVID-19 – WalletHub Study
With frontline health care workers and other vulnerable populations like the elderly first in line to receive COVID-19 vaccinations, WalletHub today released its report on the . . .
Posted on 12/10/20
Cyrano Therapeutics Raises $12.8 Million
Cyrano Therapeutics, a clinical stage regenerative medicine company developing a novel intranasal therapy for smell and flavor restoration, has raised $12.8 million in a Series A . . .
Posted on 12/10/20
Faze Medicines Launches With $81 Million Series A
Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced its launch and Series A financing of $81 . . .
Posted on 12/10/20
Catalio Capital Join $81 Million Series A for Faze Medicines
Faze Medicines, a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced its launch and Series A financing of $81 . . .
Posted on 12/10/20
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
We could be only days away from the first two emergency use authorizations (EUA) for COVID-19 vaccines in the U.S. An FDA advisory committee meets on . . .
Posted on 12/10/20
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are heading for the finish line in the coronavirus vaccine race. The U.S. Food and Drug Administration will meet with advisory . . .
Posted on 12/10/20
Is Johnson & Johnson a Great Dividend Stock?
A seemingly "boring" product line up can often make a company a great investment. Think about how many mundane things like shampoo or skin moisturizer you . . .
Posted on 12/10/20
Could Pfizer Be a Millionaire-Maker Stock?
In the past month, Pfizer (NYSE:PFE) stock is up over 20% on the enthusiasm that it will be the first company in the world to bring . . .
Posted on 12/10/20
Here's What Could Make Moderna's COVID Vaccine a Bigger Winner Than Pfizer's
We could be only days away from the first two emergency use authorizations (EUA) for COVID-19 vaccines in the U.S. An FDA advisory committee meets on . . .
Posted on 12/10/20
After Moderna and Pfizer, Which Vaccine Makers May Cross the Finish Line Next?
Pfizer (NYSE:PFE) and Moderna (NASDAQ:MRNA) are heading for the finish line in the coronavirus vaccine race. The U.S. Food and Drug Administration will meet with advisory . . .
Posted on 12/10/20
Is Biogen Getting Desperate?
Due to drastic measures being taken to stop the spread of the coronavirus, people around the world have had far less social interaction this year, which . . .
Posted on 12/10/20
Moderna Stock: Buy at the High?
Moderna (NASDAQ:MRNA) shares have soared by more than 768% this year. Right now, they're sitting at an all-time high. The clinical-stage biotech company was among the . . .
Posted on 12/10/20
Is Moderna Stock a Hold?
A recent downgrade from buy to hold from a Wall Street analyst has Moderna (NASDAQ:MRNA) stock under pressure. Needham analyst Alan Carr has removed his $110 . . .
Posted on 12/10/20
Nym Ranked Among Top 10 Most Promising Startups of 2020
Nym Health, the autonomous medical coding technology provider, ranked among the Top 10 Most Promising Startups of 2020, in a list released by Globes financial newspaper.Nym . . .
Posted on 12/9/20
Maryland Coronavirus Hospitalizations Reach Pandemic High of 1,715, Breaking Record from April
The number of Marylanders currently hospitalized due to coronavirus reached a pandemic high of 1,715 patients on Wednesday.The state’s previous highest number of coronavirus-related hospitalizations was . . .
Posted on 12/9/20
Cyclo Therapeutics Prices of $12.5 Million Public Offering
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (NasdaqCM: CYTH) (NasdaqCM:CYTHW), a clinical stage biotechnology company developing a cyclodextrin platform for the treatment of Neurodegenerative Diseases, including their lead candidate . . .
Posted on 12/9/20
Rocket Pharmaceuticals Proposes Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces that . . .
Posted on 12/9/20
One Medical to Open Buckhead Location This December
Tech-Powered and Human-Centered Primary Care Practice Debuts Third Atlanta OfficeOne Medical, the modern membership-based primary care organization, is bringing its human-centered, technology-powered healthcare to its third . . .
Posted on 12/9/20
Conversion Labs Approved for Nasdaq Capital Market Listing
NEW YORK, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Conversion Labs, Inc. (OTCQB: CVLB), a direct-to-consumer telemedicine and wellness company, has received approval to uplist to the . . .
Posted on 12/9/20
Veru Reports Record Fiscal 2020 Fourth Quarter and Record Full-Year Financial Results
MIAMI, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of . . .
Posted on 12/9/20
HOOKIPA Pharma Proposes Public Offering of Common Stock and Preferred Stock
NEW YORK and VIENNA, Austria, Dec. 08, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on . . .
Posted on 12/9/20
EyePoint Pharmaceuticals Announces 1-for-10 Reverse Stock Split
WATERTOWN, Mass., Dec. 08, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced . . .

